- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04241939
Telephone Counseling and Numberless Scales to Overcome Barriers to Adolescent Weight Loss
November 6, 2020 updated by: The University of Texas Medical Branch, Galveston
Brief Telephone Counseling and Numberless Scales to Overcome Weight Loss Barriers in Underserved Adolescents
This study tests the feasibility and acceptability of a numberless behavioral digital scale (BDS) intervention combined with motivational interviewing (MI) to affect lifestyle changes to promote weight loss in adolescents who are obese.
Half of the participants will receive this intervention, while the other half will use a digital scale along with the standard adolescent weight loss program.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The proposed pilot project seeks to enhance motivation for lifestyle change in adolescents who are obese.
It will test a novel intervention that combines modified MI-based counseling and BDS.
We will test the feasibility of the intervention over a 12-week period, with 24-week follow-up compared to use of standard digital scale.
All participants will undergo the standard adolescent weight loss program, which includes monthly clinic visits with dietary and physical activity counseling.
The MI intervention will include modified MI, brief weekly telephone reinforcement, and use of a BDS.
The BDS with its mobile app offers daily feedback through colors, daily missions to promote healthy habits, and weekly healthy tips from nutritionists.
In addition to the primary outcome of feasibility (daily weighing) investigators will also explore the intervention's effect on motivation, psychological outcomes and various aspects of feasibility and acceptability.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
League City, Texas, United States, 77573
- UTMB
-
Webster, Texas, United States, 77598
- UTMB
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age between 12 and 18 years
- BMI greater than or equal to 95th percentile for age and sex group or BMI greater than or equal to 35 kg/m^2
- Participant (not parent) is able to read and understand English (app is in English)
- Smartphone device with Wi-Fi and app capability
- Willingness to be randomized to any condition
Exclusion Criteria:
Age 19 years or older
- Developmental delay
- Inability to provide informed consent
- Any medical condition that, in the opinion of the PI, would place the participant at increased risk
- Use of an investigational agent in the 30 days prior to signing informed consent
- History of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction) that would , in the opinion of the PI, make it difficult for the participant to comply with study procedures or follow instructions
- Females who are pregnant or lactating, by verbal report
- Pre-existing conditions (i.e paralysis, heart failure, severe autism or mental retardation, psychosis, etc.)
- Prisoners
- Lack of transportation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Numberless BDS and Modified-MI
Use of numberless BDS (color coded), app, and motivational interviewing.
Participants will weigh daily and receive weekly motivational interviewing at clinic visits and via a weekly phone call.
|
Participants perform daily weighing using a numberless BDS with feedback from app (color codes, challenges), in conjunction with modified motivational interviewing (clinic visits and weekly telephone calls), and the standard adolescent weight loss program.
Modified motivational interviewing (clinic visits and weekly telephone calls), and the standard adolescent weight loss program.
|
Active Comparator: Digital Scale
Use standard digital scale (number readout).
Participants will weigh daily.
|
Participants perform daily weighing using a digital scale (number readout), in conjunction with standard adolescent weight loss program
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility of Modified MI and BDS
Time Frame: 24 weeks
|
Attendance at in-clinic visits, completion of weekly phone calls, and daily weighing based on BDS app data collected at 24 week assessment.
|
24 weeks
|
Acceptability of Modified MI and BDS
Time Frame: 24 weeks
|
Number of participants in each group who are lost to follow-up
|
24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anthropometrics
Time Frame: 24 weeks
|
Body Mass Index (BMI)
|
24 weeks
|
Bio-impedence measures
Time Frame: 24 weeks
|
Measures body fat (%)
|
24 weeks
|
Anxiety
Time Frame: Change from 0 to 24 weeks
|
Self-reported anxiety on a scale from 0 (not at all) to 3 (severely) using the Beck Anxiety Inventory
|
Change from 0 to 24 weeks
|
Depression
Time Frame: Change from 0 to 24 weeks
|
Self-reported depression screening on a scale from 0 (not at all) to 3 (nearly every day) using the PHQ-9: Modified for Teens
|
Change from 0 to 24 weeks
|
Bio-impedence measures
Time Frame: 24 weeks
|
Measures muscle mass (%)
|
24 weeks
|
Bio-impedence measures
Time Frame: 24 weeks
|
Measures visceral fat (%)
|
24 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Kanika Bowen-Jallow, MD, MMS, University of Texas
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 14, 2020
Primary Completion (Actual)
September 14, 2020
Study Completion (Actual)
September 14, 2020
Study Registration Dates
First Submitted
January 9, 2020
First Submitted That Met QC Criteria
January 22, 2020
First Posted (Actual)
January 27, 2020
Study Record Updates
Last Update Posted (Actual)
November 9, 2020
Last Update Submitted That Met QC Criteria
November 6, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-0198
- K12HD052023 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
The investigators will provide access to all data, regardless of publication, collected on this project.
All external investigators must supply a written request identifying their research questions (s) and specifying the data they would like to analyze.
The request must include a data security plan and explanation of how the data would be stored and who would have access.
IPD Sharing Time Frame
Data available upon request
IPD Sharing Access Criteria
All external investigators must supply a written request identifying their research questions (s) and specifying the data they would like to analyze.
The request must include a data security plan and explanation of how the data would be stored and who would have access.
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Fundació Sant Joan de DéuNot yet recruitingObesity, Childhood | Obesity, AdolescentSpain
-
Consorcio Centro de Investigación Biomédica en...Maimónides Biomedical Research Institute of Córdoba; Instituto de Salud Carlos... and other collaboratorsActive, not recruiting
-
University of HoustonBaylor College of MedicineCompleted
Clinical Trials on Numberless BDS
-
Jazz PharmaceuticalsCompletedUlcerative ColitisUnited Kingdom
-
Constellation PharmaceuticalsActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
Julio RamirezUniversity of LouisvilleTerminatedOsteomyelitisUnited States